5Reid IR, Brown JP, Burckhardt P, et al. Intravenous zoledronic acid in postmenopausal women with low bone mineral density[J]. N Engl J Med, 2002, 346(9) :653-661. 被引量：1
6Gallagher JC, Baylink DJ, Freeman R & Mc Clung MR. Prevention of bone loss with tibolone in postmenopausal women: results form the MORE randomized trial. Multiple Outcomes of Raloxifene Evaluationl [J]. Journal of Clinical Endocrinology and Metabolism, 2001,86(10) :4717-4726. 被引量：1
